For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...

The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...

The 76-year-old journalist went public with his diagnosis last month, saying his first symptom was “forgetting people’s names ...

Actinogen Medical Ltd (ASX:ACW, OTC:ATGGF) has outlined the scientific rationale supporting its lead drug candidate Xanamem® ...

The U.S. Food and Drug Administration (FDA) recently approved Leqembi, a drug indicated to treat Alzheimer’s disease in patients with mild cognitive impairment. The FDA granted Leqembi an Accelerated ...

Alzheimer’s disease disproportionately affects women. Of the roughly seven million Americans living with the condition, ...

Researchers created a 3D human brain tissue model using stem cells to model Alzheimer's plaque clearance and enable automated ...

A new study shows ImmunoBrain anti-PD-L1 antibody IBC-Ab002 is safe and reduces neurodegenerative biomarkers in Alzheimer's.

Seventy-nine percent of voters — including 78% of independents — support better access to coverage for Alzheimer’s detection ...

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow ...

By detecting the subtle brain changes and damage to nerve cells years before memory or language issues surface, the blood test allows patients to seek treatment during the window when therapies are ...